Abstract:Objectives: This study aims to explore how disease and health-related quality of life (HRQOL) factors are associated with self-reported physical capacity in walking, jogging and running in systemic lupus erythematosus (SLE). Patients and methods: This cross-sectional study is part of an ongoing cohort research project which started in 2014. A total of 198 patients (21 males, 177 females; mean age 51.5±16.1 years; range, 20 to 82 years) with SLE answered a question concerning physical capacity and the answers were categorized as low (can walk less than 2 km) and high (can jog and run at least 2 km) capacity. Additional measurements of disease activity (Systemic Lupus Activity Measure-Revised, SLAM-R), organ damage (Systemic Lupus International Collaborating Clinics-Damage Index, SLICC-DI), physical activity (International Physical Activity Questionnaire-Short Form, IPAQ-SF), exercise during the past year, Hospital Anxiety and Depression Scale (HADS), and HRQOL according to EuroQol five-dimension score and EuroQol visual analog scale (EQ-VAS) were included. The independent variables in the multiple logistic regression analysis were age, body mass index (BMI), disease duration, SLAM-R, SLICC-DI, IPAQ-SF category, sitting hours (IPAQ-SF), and exercise during the past year as well as HADS and EQ-VAS. Results: Patients that reported low physical capacity (n=120) were older (p<0.001), had longer disease duration (p<0.001), had more organ damage (p<0.001), reported that they were less physically active (p=0.003), exercised less during the past year (p=0.001), reported more pain/discomfort and depressive symptom (p<0.001) and had lower overall HRQOL (p<0.001) and mobility and usual activities than those that reported high capacity (n=78). The regression analysis showed that age (median ≤49 vs >49) (Exp) (B): 4.52 (95% confidence interval [CI]: 2.05 to 9.98) (p<0.001), disease duration (median ≤17 vs >17) Exp (B): 2.53 (95% CI: 1.15 to 5.60) (p=0.02), SLICC-DI (median <1 vs ≥1) Exp (B): 3.60 (95% CI: 1.48 to 8.73) (p=0.005), and EQ-VAS (median <72 vs ≥72) Exp (B): 4.63 (95% CI: 2.13 to 10.05) (p<0.001) were significant factors associated with physical capacity (Nagelkerke R Squared=0.46). Conclusion: Patients with low physical capacity were less physically active, exercised less and had more pain and depressive symptoms than those that reported a high capacity. However, only age, disease duration, organ damage and overall HRQOL were indicators of low physical capacity. In order to increase physical capacity in the management of SLE, it is important to address overall HRQOL.

Limitations in Activities of Daily Living among Individuals with Systemic Lupus Erythematosus

Factors associated with self-reported capacity to walk, jog and run in individuals with systemic lupus erythematosus

Association of Limited Health Literacy With Clinical and Patient-Reported Outcomes in Individuals With Systemic Lupus Erythematosus

P161 Self-reported barriers to exercise from a national United Kingdom systemic lupus erythematosus cohort

SAT0282 Frequency and Predictors of Attainment of the Lupus Low Disease Activity State (LLDAS) in A Cross Sectional Study of Sle Patients in the Asia Pacific

Patient-reported outcomes and healthcare resource utilization in systemic lupus erythematosus: impact of disease activity

Relationships between person and health factors and job characteristics in women with systemic lupus erythematosus

Quality of life measures and physical activity in childhood systemic lupus erythematosus

Association of the Lupus Low Disease Activity State (LLDAS) with Health-Related Quality of Life

Predictors of predominant Lupus Low Disease Activity State (LLDAS-50)

Lupus Low Disease Activity State and organ damage in relation to quality of life in systemic lupus erythematosus: a cohort study with up to 11 years of follow-up

Depression-, Pain-, and Health-Related Quality of Life in Patients with Systemic Lupus Erythematosus

Differential impact of disease activity and damage on health-related quality of life in patients with systemic lupus erythematosus

Characterisation and outcomes of different subsets of low disease activity states in patients with systemic lupus erythematosus

Disease Chronicity and Activity Predict Subclinical Left Ventricular Systolic Dysfunction in Patients with Systemic Lupus Erythematosus.

Frequency and Predictors of the Lupus Low Disease Activity State in a Multi-National and Multi-Ethnic Cohort

An exploration of patient-reported symptoms in systemic lupus erythematosus and the relationship to health-related quality of life

Impact of disease activity patterns on health-related quality of life (HRQoL) in patients with systemic lupus erythematosus (SLE)

Association of the Lupus Low Disease Activity State (lldas) with Health-Related Quality of Life in A Multinational Prospective Study

Comparison of Attainment and Protective Effects of Lupus Low Disease Activity State in Patients with Newly Diagnosed Versus Established Systemic Lupus Erythematosus.

Assessment of cutaneous disease activity in early lupus and its correlation with quality of life: a cross-sectional study